复方红藤合剂联合屈螺酮炔雌醇片、妇炎康胶囊治疗宫腔镜子宫内膜息肉切除术后临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R713.4

基金项目:


Clinical Study of Compound Hongteng Mixture Combined with Drospirenone and Ethinylestradiol Tablets and Fuyankang Capsules for Patients After Hysteroscopic Endometrial Polypectomy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察复方红藤合剂联合屈螺酮炔雌醇片、妇炎康胶囊治疗宫腔镜子宫内膜息肉切除术后患 者的临床效果。方法:选取80 例湿热血瘀型子宫内膜息肉患者,随机分为对照组和联合组各40 例。2 组均行 宫腔镜子宫内膜息肉切除术治疗,术后均采用妇炎康胶囊与屈螺酮炔雌醇片治疗,联合组加予复方红藤合剂治 疗。2 组疗程均为3 个月经周期,随访3 个月。治疗前后评定中医证候评分,观察月经恢复情况(记录经期、 月经量、子宫内膜厚度),检测性激素指标[雌二醇(E2)、黄体生成素(LH)、卵泡生成激素(FSH) ]、炎症因 子指标[C-反应蛋白(CRP)、白细胞介素-4(IL-4) ]。统计临床疗效、月经改善率、不良反应发生率及子宫内 膜息肉复发率。结果:治疗后,联合组临床疗效总有效率(95.00%) 高于对照组(75.00%),差异有统计学意 义(P<0.05)。2 组中医证候积分均较治疗前减少(P<0.05)。联合组中医证候积分低于对照组(P<0.05)。 2 组经期均较治疗前缩短,月经量均较治疗前减少,子宫内膜厚度均薄于治疗前,差异均有统计学意义(P< 0.05)。联合组经期短于对照组,月经量少于对照组,子宫内膜厚度薄于对照组,差异均有统计学意义(P< 0.05)。联合组月经改善率高于对照组(P<0.05)。2 组血清E2、LH、FSH 水平均较治疗前降低(P<0.05)。联 合组血清E2、LH、FSH 水平均低于对照组(P<0.05)。2 组血清CRP 水平均较治疗前降低,血清IL-4 水平均较 治疗前升高,差异均有统计学意义(P<0.05)。联合组血清CRP 水平低于对照组,血清IL-4 水平高于对照组, 差异均有统计学意义(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。随访3 个月,联合 组复发率低于对照组(P<0.05)。结论:采用复方红藤合剂联合屈螺酮炔雌醇片、妇炎康胶囊治疗宫腔镜子宫内 膜息肉切除术后患者,可减少月经量,调节性激素水平,减轻炎症反应,有效预防息肉复发,安全有效。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of Compound Hongteng Mixture combined with Drospirenone and Ethinylestradiol Tablets and Fuyankang Capsules on patients after hysteroscopic endometrial polypectomy. Methods:A total of 80 patients with endometrial polyps of dampheat with blood stasis type were selected and randomly divided into the control group and the combination group,with 40 cases in each group. The two groups were given hysteroscopic endometrial polypectomy for treatment, after which the two groups were treated with Drospirenone and Ethinylestradiol Tablets and Fuyankang Capsules and the combination group was additionally treated with Compound Hongteng Mixture. The two groups were treated for three menstrual cycles and followed up for 3 months. The traditional Chinese medicine (TCM) syndrome scores were evaluated before and after treatment; the menstruation recovery was observed by recording the menstrual period,menstrual volume and endometrial thickness; the levels of sex hormones, including estradiol (E2), luteinizing hormone (LH) and follicle- stimulating hormone (FSH),and of inflammatory factors,including C-reactive protein (CRP) and interleukin- 4 (IL- 4) were detected. The clinical effects,improvement rate of menstruation,incidence of adverse reactions and recurrence rate of endometrial polyps were counted. Results:After treatment,the total clinical effective rate was 95.00% in the combination group,higher than that of 75.00% in the control group,the difference being significant (P<0.05). The TCM syndrome scores in the two groups were decreased when compared with those before treatment,and the TCM syndrome score in the combination group was lower than that in the control group (P<0.05). The menstrual period in the two groups were shortened when compared with those before treatment, the menstrual volume were reduced when compared with those before treatment, and the endometrial thickness were thinner than those before treatment, differences being significant (P<0.05). The menstrual period in the combination group was shorter than that in the control group,the menstrual volume was less than that in the control group,and the endometrial thickness was thinner than that in the control group, differences being significant (P<0.05). The improvement rate of menstruation in the combination group was higher than that in the control group (P<0.05). The levels of serum E2,LH and FSH in the two groups were decreased when compared with those before treatment (P< 0.05),and the above levels in the combination group were lower than those in the control group (P<0.05). The serum CRP levels in the two groups were decreased when compared with those before treatment, and the serum IL-4 levels were increased when compared with those before treatment,differences being significant (P<0.05). The serum CRP level in the combination group was lower than that in the control group,and the serum IL- 4 level was higher than that in the control group,differences being significant (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P>0.05). After follow- up for 3 months, the recurrence rate in the combination group was lower than that in the control group (P<0.05). Conclusion: The therapy of Compound Hongteng Mixture combined with Drospirenone and Ethinylestradiol Tablets and Fuyankang Capsules has a good curative effect on patients after hysteroscopic endometrial polypectomy,which can reduce the menstrual volume,regulate the levels of sex hormones,mitigate the inflammatory responses and effectively prevent the recurrence of polyps with good safety.

    参考文献
    相似文献
    引证文献
引用本文

李永陈,钱敏英,李曼曼.复方红藤合剂联合屈螺酮炔雌醇片、妇炎康胶囊治疗宫腔镜子宫内膜息肉切除术后临床研究[J].新中医,2024,56(4):74-79

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-02-28
  • 出版日期: